1. Transcatheter mitral valve interventions for mitral regurgitation, with special focus on MitraClip: The position of Spanish, Portuguese and Italian interventional societies
- Author
-
Xavier Freixa, Rui Campante-Teles, Giuseppe Tarantini, Bruno Melica, Rodrigo Estévez-Loureiro, Dabit Arzamendi, Manuel Pan, Armando Pérez de Prado, and Giuseppe Musumeci
- Subjects
medicine.medical_specialty ,Population ageing ,Consensus ,Psychological intervention ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Mitral valve ,medicine ,MitraClip ,Transcatheter mitral valve interventions ,Cardiology and Cardiovascular Medicine ,Humans ,In patient ,cardiovascular diseases ,030212 general & internal medicine ,Intensive care medicine ,Societies, Medical ,Randomized Controlled Trials as Topic ,Heart Valve Prosthesis Implantation ,Mitral regurgitation ,Portugal ,business.industry ,valvular heart disease ,Mitral Valve Insufficiency ,Surgical Instruments ,medicine.disease ,medicine.anatomical_structure ,Italy ,Spain ,cardiovascular system ,Cardiology ,Position paper ,business - Abstract
Mitral regurgitation is a common valvular heart disease and its prevalence is expected to increase with population ageing. In the recent years we have witnessed the evolution of several transcatheter devices to correct mitral regurgitation in patients at high-risk for surgery. Most of the evidence of the safety and efficacy of this new therapy comes from MitraClip studies. However, new alternatives have emerged with promising results. The aim of this position paper is to review the current evidence regarding patient selection, expected results and timing for transcatheter mitral valve interventions from the perspective of three European interventional societies. (C) 2017 Elsevier B.V. All rights reserved.
- Published
- 2017